about
Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elementsAdsorptive and acidic properties, reversible lattice oxygen evolution, and catalytic mechanism of cryptomelane-type manganese oxides as oxidation catalysts.Target motifs affecting natural immunity by a constitutive CRISPR-Cas system in Escherichia coli.CRISPR Content Correlates with the Pathogenic Potential of Escherichia coliRecent advances in the textural characterization of hierarchically structured nanoporous materials.A mesostructured Y zeolite as a superior FCC catalyst--lab to refinery.CRISPR-Cas functional module exchange in Escherichia coli.Mesoporous materials for clean energy technologies.Hierarchical zeolites and their catalytic performance in selective oxidative processes.Prevalence and microdiversity of Alteromonas macleodii-like microorganisms in different oceanic regions.A stable luminescent hybrid mesoporous copper complex-silica.Ultrasonic tissue characterization for monitoring nanostructured TiO2-induced bone growth.Mesostructured zeolites: bridging the gap between zeolites and MCM-41.Terminology of metal–organic frameworks and coordination polymers (IUPAC Recommendations 2013)Coordination polymers, metal–organic frameworks and the need for terminology guidelinesIncorporation of chemical functionalities in the framework of mesoporous silicaProbe Molecule Kinetic Studies of Adsorption on MCM-41Incorporation of cubane-type Mo3S4 molybdenum cluster sulfides in the framework of mesoporous silicaThermochemistry of Surfactant‐Templating of USY ZeoliteUltrasmall Zeolite L Crystals Prepared from Highly Interdispersed Alkali-Silicate PrecursorsThe Energetics of Surfactant-Templating of ZeolitesVisible-Light-Activated Black Organotitanias: How Synthetic Conditions Influence Their Structure and Photocatalytic ActivitySingle-step synthesis of manganese oxide octahedral molecular sieves with large pore sizesControversies, compromises and the common chemical languageSurfactant-templated zeolites for the production of active pharmaceutical intermediates
P50
Q29615788-94665ADC-BE81-451E-9452-CBE986A7EB4CQ33319611-6AD690DE-D2F0-4F3A-924C-144056450733Q34494161-3BBF0A21-BA2E-471C-AF86-667B71DF5F27Q35681328-64521135-3332-4145-AB85-2B0BDA38A51BQ38984909-7E4778BF-F0F9-4AA0-A93A-22CE4613334BQ39558990-B9539633-D4E5-4ED2-B9FC-F5E900974C36Q41893501-C82BCFEA-C1F5-4657-AB84-2D1879743495Q46910121-F42EB0C8-1F56-41B0-BFB9-9FAED06EFB3EQ47729213-9EC915CB-1A50-452E-BF6E-F22BD98718F2Q48307776-E4CAA734-B021-42A6-BE15-FDF3D08E5ECDQ50244967-AE724390-CB59-4FAB-B769-1B1E07990832Q50947982-7603CD51-A09E-4348-968D-B26F81686A68Q53224482-D46C3A32-6D18-441F-A273-408DEADE2C8DQ56907826-234DFC2C-2045-4C1A-AF25-9F256DD013BBQ57732539-89C23E27-A3C0-4753-99C2-A58F86540AA5Q58348826-E3A5CDAD-54E1-4303-A1E0-C54DAFCF8950Q60217932-7AED1A02-0DE0-4455-89DA-6780898CD578Q60221282-BFDDBE28-BD40-46B8-B182-E396DBD95FF0Q67229058-06816E4A-967C-4626-A5B6-59BC93B8C9F2Q67229067-F4D76470-D3AC-4125-B81B-42EC5BD7FE77Q67229074-2AB2E76D-8112-4382-B46F-705087424A5CQ67229083-6839F808-A21A-48AB-9C07-B3631D9AB354Q67229139-E0D6B148-D0FD-4517-ABB6-450E54585F2BQ90242808-08344B60-3B25-4D52-B6DB-CF4AF119FBD5Q90624785-3CAFAEF9-CC87-456B-8A48-D97106E719A9
P50
description
Chemist
@en
onderzoeker
@nl
հետազոտող
@hy
name
Javier Garcia-Martinez
@ast
Javier Garcia-Martinez
@en
Javier Garcia-Martinez
@es
Javier Garcia-Martinez
@nl
type
label
Javier Garcia-Martinez
@ast
Javier Garcia-Martinez
@en
Javier Garcia-Martinez
@es
Javier Garcia-Martinez
@nl
prefLabel
Javier Garcia-Martinez
@ast
Javier Garcia-Martinez
@en
Javier Garcia-Martinez
@es
Javier Garcia-Martinez
@nl
P214
P244
P950
P106
P1153
7004817771
P1960
GVWEqc8AAAAJ
P21
P214
P244
nb2010005460
P31
P496
0000-0002-7089-4973
P569
1973-01-01T00:00:00Z
P735
P7859
lccn-nb2010005460